To eliminate cervical cancer in Canada, nationwide funding of self-sampling for human papillomavirus is needed.
作者信息
Charlebois Shannon, Kean Sarah
机构信息
Medical editor, CMAJ (Charlebois); CancerCare Manitoba (Kean), Winnipeg, Man.
出版信息
CMAJ. 2024 Jun 2;196(21):E729-E730. doi: 10.1503/cmaj.240722.
Abstract
摘要
相似文献
1
To eliminate cervical cancer in Canada, nationwide funding of self-sampling for human papillomavirus is needed.
CMAJ. 2024 Jun 2;196(21):E729-E730. doi: 10.1503/cmaj.240722.
2
Acceptance of Self-Sampling and Knowledge about Human Papillomavirus among Women in Mongolia.
Asian Pac J Cancer Prev. 2024 May 1;25(5):1823-1829. doi: 10.31557/APJCP.2024.25.5.1823.
3
Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
BMC Cancer. 2020 Jul 13;20(1):645. doi: 10.1186/s12885-020-07085-9.
4
Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
J Womens Health (Larchmt). 2019 Aug;28(8):1094-1104. doi: 10.1089/jwh.2018.7141. Epub 2019 Mar 15.
5
Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.
Sex Transm Dis. 2015 Nov;42(11):655-9. doi: 10.1097/OLQ.0000000000000345.
6
Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
BMC Cancer. 2017 Nov 9;17(1):734. doi: 10.1186/s12885-017-3723-5.
7
The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening.
Rev Med Virol. 2011 May;21(3):139-53. doi: 10.1002/rmv.686.
8
Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
Women Health. 2021 Jan;61(1):83-94. doi: 10.1080/03630242.2020.1831683. Epub 2020 Oct 26.
9
Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
BMJ Open. 2016 Oct 8;6(10):e011754. doi: 10.1136/bmjopen-2016-011754.
10
Feasibility and acceptability of human papillomavirus self-sampling compared with clinician sampling in urban areas of western China: a cross-sectional survey.
Front Public Health. 2025 Apr 23;13:1524796. doi: 10.3389/fpubh.2025.1524796. eCollection 2025.
本文引用的文献
1
Strategies to accelerate the elimination of cervical cancer in British Columbia, Canada: a modelling study.
CMAJ. 2024 Jun 2;196(21):E716-E723. doi: 10.1503/cmaj.231682.
2
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.
Am J Prev Med. 2024 Mar;66(3):540-547. doi: 10.1016/j.amepre.2023.10.020. Epub 2023 Nov 5.
3
Age-Specific Trends of Invasive Cervical Cancer Incidence in British Columbia, Canada, 1971-2017.
Curr Oncol. 2023 Aug 18;30(8):7692-7705. doi: 10.3390/curroncol30080557.
4
Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening.
JAMA Netw Open. 2023 Mar 1;6(3):e234052. doi: 10.1001/jamanetworkopen.2023.4052.
5
Disability and Participation in Breast and Cervical Cancer Screening: A Systematic Review and Meta-Analysis.
Int J Environ Res Public Health. 2022 Aug 2;19(15):9465. doi: 10.3390/ijerph19159465.
6
Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
BMC Cancer. 2020 Jul 13;20(1):645. doi: 10.1186/s12885-020-07085-9.
7
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
Clin Microbiol Infect. 2020 May;26(5):579-583. doi: 10.1016/j.cmi.2019.09.006. Epub 2019 Sep 17.
8
Assessing the impact of mailing self-sampling kits for human papillomavirus testing to unscreened non-responder women in Manitoba.
Curr Oncol. 2019 Jun;26(3):167-172. doi: 10.3747/co.26.4575. Epub 2019 Jun 1.
9
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.
Lancet Oncol. 2019 Feb;20(2):229-238. doi: 10.1016/S1470-2045(18)30763-0. Epub 2019 Jan 15.
10
Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
JAMA. 2018 Aug 21;320(7):687-705. doi: 10.1001/jama.2018.10400.
Zotero 插件